OSIR

Osiris Therapeutics, Inc. News Headlines

$14.89
*  
0.40
2.62%
Get OSIR Alerts
*Delayed - data as of Jul. 11, 2014  -  Find a broker to begin trading OSIR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Biogen's Earnings Surpass Expectations - Analyst Blog
4/25/2013 12:14:51 PM - Zacks.com

Sanofi's Vaccine Gets EU Approval - Analyst Blog
4/22/2013 12:09:57 PM - Zacks.com

An Industry Outlook With Analyst Vernon Bernardino
4/22/2013 5:30:00 AM - Seeking Alpha

Vertex CF Candidate Impresses - Analyst Blog
4/19/2013 3:40:01 PM - Zacks.com

Investing In The Stem Cell Sector: An Overview
4/17/2013 8:36:00 AM - Seeking Alpha

Osiris Therapeutics, Inc. Enters Oversold Territory - Tale of the Tape
4/12/2013 12:06:01 PM - Zacks.com

Alkermes Announces Restructuring Plan - Analyst Blog
4/11/2013 5:06:42 PM - Zacks.com

Affymetrix to Disappoint in 1Q - Analyst Blog
4/10/2013 9:10:00 AM - Zacks.com

The Vatican / NeoStem Partnership Looks To Create Interest And Advance Cell Therapy
4/10/2013 4:00:00 AM - Seeking Alpha

Patients Dosed in Arena Study - Analyst Blog
4/9/2013 6:09:14 PM - Zacks.com

Sanofi Unveils Bond Issue Pricing - Analyst Blog
4/9/2013 4:08:12 PM - Zacks.com

ISIS Initiates ISIS-APOA Study - Analyst Blog
4/8/2013 6:09:14 PM - Zacks.com

Glaxo Eyes Benlysta Label Expansion - Analyst Blog
4/5/2013 3:09:05 PM - Zacks.com

AstraZeneca Takes Over AlphaCore - Analyst Blog
4/4/2013 5:09:40 PM - Zacks.com

Perrigo Touches 52-Week High - Analyst Blog
4/3/2013 9:23:05 AM - Zacks.com

Perrigo Buys Velcera - Analyst Blog
4/2/2013 5:24:35 PM - Zacks.com

Celgene Reaches 52-Week High - Analyst Blog
4/2/2013 10:08:11 AM - Zacks.com

Gilead's HCV Study to Continue - Analyst Blog
4/1/2013 5:05:01 PM - Zacks.com

Bad News for Alexion, Shares Down - Analyst Blog
4/1/2013 4:07:41 PM - Zacks.com

Acorda Reports Data on Epilepsy Drug - Analyst Blog
3/26/2013 4:27:57 PM - Zacks.com

Opexa: A Significant Growth Opportunity For Short-Term Traders And Long-Term Investors
3/26/2013 9:01:00 AM - Seeking Alpha

SGEN Seeks Adcetris Label Expansion - Analyst Blog
3/19/2013 7:15:01 PM - Zacks.com

AstraZeneca to Revamp R&D Structure - Analyst Blog
3/19/2013 5:47:17 PM - Zacks.com

Cell Therapy Leader Stephen Potter Talks Osiris, NeoStem And The Industry Itself
3/19/2013 9:15:00 AM - Seeking Alpha

Theravance Inks Deal for Vibativ - Analyst Blog
3/18/2013 4:44:02 PM - Zacks.com